Literature DB >> 30196404

3D Bioprinting and Stem Cells.

Caitlyn A Moore1, Niloy N Shah2, Caroline P Smith1, Pranela Rameshwar3.   

Abstract

Three-dimensional (3D) in vitro modeling is increasingly relevant as two-dimensional (2D) cultures have been recognized with limits to recapitulate the complex endogenous conditions in the body. Additionally, fabrication technology is more accessible than ever. Bioprinting, in particular, is an additive manufacturing technique that expands the capabilities of in vitro studies by precisely depositing cells embedded within a 3D biomaterial scaffold that acts as temporary extracellular matrix (ECM). More importantly, bioprinting has vast potential for customization. This allows users to manipulate parameters such as scaffold design, biomaterial selection, and cell types, to create specialized biomimetic 3D systems.The development of a 3D system is important to recapitulate the bone marrow (BM) microenvironment since this particular organ cannot be mimicked with other methods such as organoids. The 3D system can be used to study the interactions between native BM cells and metastatic breast cancer cells (BCCs). Although not perfect, such a system can recapitulate the BM microenvironment. Mesenchymal stem cells (MSCs), a key population within the BM, are known to communicate with BCCs invading the BM and to aid in their transition into dormancy. Dormant BCCs are cycling quiescent and resistant to chemotherapy, which allows them to survive in the BM to resurge even after decades. These persisting BCCs have been identified as the stem cell subset. These BCCs exhibit self-renewal and can be induced to differentiate. More importantly, this BCC subset can initiate tumor formation, exert chemoresistance, and form gap junction with endogenous BM stroma, including MSCs. The bioprinted model detailed in this chapter creates a MSC-BC stem cell coculture system to study intercellular interactions in a model that is more representative of the endogenous 3D microenvironment than conventional 2D cultures. The method can reliably seed primary BM MSCs and BC stem cells within a bioprinted scaffold fabricated from CELLINK Bioink. Since bioprinting is a highly customizable technique, parameters described in this method (i.e., cell-cell ratio, scaffold dimensions) can easily be altered to serve other applications, including studies on hematopoietic regulation.

Entities:  

Keywords:  3D bioprinting; Alginate; Bone marrow; Breast cancer; Dormancy; Extracellular matrix; Stem cells

Mesh:

Substances:

Year:  2018        PMID: 30196404     DOI: 10.1007/978-1-4939-8697-2_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Three-Dimensional Printing for Craniofacial Bone Tissue Engineering.

Authors:  Chen Shen; Lukasz Witek; Roberto L Flores; Nick Tovar; Andrea Torroni; Paulo G Coelho; F Kurtis Kasper; Mark Wong; Simon Young
Journal:  Tissue Eng Part A       Date:  2020-10-01       Impact factor: 3.845

Review 2.  Restoration of olfactory dysfunctions by nanomaterials and stem cells-based therapies: Current status and future perspectives.

Authors:  Shin Hyuk Yoo; Hae-Won Kim; Jun Hee Lee
Journal:  J Tissue Eng       Date:  2022-03-23       Impact factor: 7.813

Review 3.  Trends, Advantages and Disadvantages in Combined Extracorporeal Lung and Kidney Support From a Technical Point of View.

Authors:  Ana Martins Costa; Frank Halfwerk; Bettina Wiegmann; Michael Neidlin; Jutta Arens
Journal:  Front Med Technol       Date:  2022-06-21

Review 4.  Recent Trends in Decellularized Extracellular Matrix Bioinks for 3D Printing: An Updated Review.

Authors:  Kevin Dzobo; Keolebogile Shirley Caroline M Motaung; Adetola Adesida
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

Review 5.  Mesenchymal Stem Cells as a Promising Cell Source for Integration in Novel In Vitro Models.

Authors:  Ann-Kristin Afflerbach; Mark D Kiri; Tahir Detinis; Ben M Maoz
Journal:  Biomolecules       Date:  2020-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.